AL
Anirudh Lochan
About Anirudh Lochan
Data last updated:
Anirudh Lochan is a Director at Ural Health Care Private Limited (since 2002) and Director at Reuben Pharmaceuticals Private Limited (since 2012). The companies operate in Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹11.54 Cr; the largest is Ural Health Care Private Limited at ₹10.33 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ural Health Care Private Limited U85110DL2002PTC116033 | Director | 01 Jul 2002 | 2002 | ₹10.33 Cr (FY 2025) | Active |
| Reuben Pharmaceuticals Private Limited U85100DL2007PTC161194 | Director | 19 Jan 2012 | 2007 | ₹1.22 Cr (FY 2025) | Active |
Board colleagues of Anirudh Lochan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rajeev Lochan | 00882177 | Ural Health Care Private Limited , Reuben Pharmaceuticals Private Limited | Director |
| Usha Rani | 01531725 | Ural Health Care Private Limited , Reuben Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anirudh Lochan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anirudh Lochan
Anirudh Lochan currently holds 2 directorships: Ural Health Care Private Limited (Director, since 01 Jul 2002, revenue ₹10.33 Cr (FY 2025)); Reuben Pharmaceuticals Private Limited (Director, since 19 Jan 2012, revenue ₹1.22 Cr (FY 2025)).
Anirudh Lochan was first appointed on 01 Jul 2002 as Director at Ural Health Care Private Limited. The most recent appointment on record is 19 Jan 2012 at Reuben Pharmaceuticals Private Limited.
The 2 current companies of Anirudh Lochan that report revenue have a combined latest revenue of ₹11.54 Cr: Ural Health Care Private Limited ₹10.33 Cr (FY 2025); Reuben Pharmaceuticals Private Limited ₹1.22 Cr (FY 2025).
The current boards of Anirudh Lochan's companies include Rajeev Lochan (Ural Health Care Private Limited), Usha Rani (Ural Health Care Private Limited).